Raymond James & Associates’s Exscientia Plc American Depositary Shares EXAI Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAI
LCM
PIM
WP
GF
MCMU
NFGH
PBPIA
Raymond James & Associates's EXAI Position: Q4 2023 in Review
Raymond James & Associates sold out of Exscientia Plc American Depositary Shares (EXAI) in Q4 2023, closing a stake of 20,828 shares — an estimated $94.1K sold.
Raymond James & Associates first reported a position in EXAI in Q1 2022 and held it in 6 quarters. The position peaked at $182K in Q1 2022. 78 funds tracked by Wall St. Rank hold EXAI as of Q4 2023.
- Raymond James & Associates reported no remaining Exscientia Plc American Depositary Shares position as of Q4 2023 after selling out during the quarter.
- Raymond James & Associates sold 20,828 Exscientia Plc American Depositary Shares shares in Q4 2023, an estimated $94.1K.
- Raymond James & Associates first reported a position in Exscientia Plc American Depositary Shares in Q1 2022 and held it in 6 quarters.
- Raymond James & Associates's Exscientia Plc American Depositary Shares position peaked at $182K in Q1 2022.
- 78 funds tracked by Wall St. Rank held Exscientia Plc American Depositary Shares as of Q4 2023.
Based on Raymond James & Associates's 13F filing for Q4 2023, filed 16 Jan 2024.